To assist you with your request regarding (lymphomes spléniques), I have outlined a structured academic-style paper based on current hematopathological classifications and clinical guidelines.
Currently considered the first-line standard of care, offering high response rates with low toxicity. Download Lymphomes splГ©niques pdf
Splenic lymphomas represent a heterogeneous group of rare B-cell neoplasms primarily involving the spleen, bone marrow, and often the peripheral blood. The most common subtype is Splenic Marginal Zone Lymphoma (SMZL). This paper reviews the clinical presentation, diagnostic criteria (histology and immunophenotype), and evolving therapeutic strategies for these malignancies. 1. Introduction To assist you with your request regarding (lymphomes
Peripheral blood smears often show "villous" lymphocytes (small cells with polar cytoplasmic projections). Immunophenotyping: Flow cytometry typically reveals The most common subtype is Splenic Marginal Zone
Treatment is indicated only for symptomatic patients (progressive cytopenia or painful splenomegaly).
Primary splenic lymphomas account for less than 1% of all non-Hodgkin lymphomas (NHL). Unlike nodal lymphomas, these diseases typically present with massive splenomegaly without significant lymphadenopathy. Accurate diagnosis is critical, as treatment varies significantly from other B-cell malignancies. 2. Classification of Splenic B-Cell Lymphomas
Diagnosis requires a multidisciplinary integration of clinical, morphological, and molecular data: